再鼎医药盘中异动早盘大幅下跌5.01%

自选股智能写手03-14

北京时间2024年03月14日21时41分，再鼎医药（ZLAB.us）股票出现异动，股价大幅下挫5.01%。截至发稿，该股报19.15美元/股，成交量3.6853万股，换手率0.04%，振幅2.68%。最近的财报数据显示，该股实现营业收入2.67亿美元，净利润-3.35亿美元，每股收益-3.46美元，毛利1.71亿美元，市盈率-5.53倍。机构评级方面，在所有11家参与评级的机构中，91%的券商...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2419600361?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-03-14 21:41","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2419600361","market":"us","top_or_hot":-1,"title":"再鼎医药盘中异动 早盘大幅下跌5.01%","media":"自选股智能写手","content":"<div>\n<p>北京时间2024年03月14日21时41分，再鼎医药（ZLAB.us）股票出现异动，股价大幅下挫5.01%。截至发稿，该股报19.15美元/股，成交量3.6853万股，换手率0.04%，振幅2.68%。最近的财报数据显示，该股实现营业收入2.67亿美元，净利润-3.35亿美元，每股收益-3.46美元，毛利1.71亿美元，市盈率-5.53倍。机构评级方面，在所有11家参与评级的机构中，91%的券商...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031421411687e78f19&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>再鼎医药盘中异动 早盘大幅下跌5.01%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n再鼎医药盘中异动 早盘大幅下跌5.01%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-03-14 21:41 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031421411687e78f19&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年03月14日21时41分，再鼎医药（ZLAB.us）股票出现异动，股价大幅下挫5.01%。截至发稿，该股报19.15美元/股，成交量3.6853万股，换手率0.04%，振幅2.68%。最近的财报数据显示，该股实现营业收入2.67亿美元，净利润-3.35亿美元，每股收益-3.46美元，毛利1.71亿美元，市盈率-5.53倍。机构评级方面，在所有11家参与评级的机构中，91%的券商...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031421411687e78f19&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ZLAB","symbol_name":"再鼎医药","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031421411687e78f19&s=b","article_id":"2419600361","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031421411687e78f19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2419600361","pubTimestamp":1710423676,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年03月14日21时41分，再鼎医药股票出现异动，股价大幅下挫5.01%。截至发稿，该股报19.15美元/股，成交量3.6853万股，换手率0.04%，振幅2.68%。再鼎医药股票所在的生物技术行业中，整体涨幅为0.16%。其相关个股中，知临集团、180 Life Sciences Corp C/Wts 07/11/2025、Nutriband Inc C/Wts 涨幅较大，Novabay Pharmaceuticals, Inc.、知临集团、Gri Bio, Inc.较为活跃，换手率分别为126.64%、104.57%、62.17%，振幅较大的相关个股有知临集团、Nutriband Inc C/Wts 、Coherus Biosciences, Inc.，振幅分别为43.88%、26.15%、16.30%。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"ZLAB":"再鼎医药","BK4526":"热门中概股","BK4548":"巴美列捷福持仓","BK4531":"中概回港概念","BK4585":"ETF&股票定投概念","BK4139":"生物科技","BK4588":"碎股"},"translate_title":"Zaiding Medicine's intraday changes fell sharply by 5.01% in early trading","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ZLAB":1},"content_text":"北京时间2024年03月14日21时41分，再鼎医药（ZLAB.us）股票出现异动，股价大幅下挫5.01%。截至发稿，该股报19.15美元/股，成交量3.6853万股，换手率0.04%，振幅2.68%。最近的财报数据显示，该股实现营业收入2.67亿美元，净利润-3.35亿美元，每股收益-3.46美元，毛利1.71亿美元，市盈率-5.53倍。机构评级方面，在所有11家参与评级的机构中，91%的券商给予买入建议，9%的券商给予持有建议，无券商给予卖出建议。再鼎医药股票所在的生物技术行业中，整体涨幅为0.16%。其相关个股中，知临集团、180 Life Sciences Corp C/Wts 07/11/2025(To Pur Com)、Nutriband Inc C/Wts (To Pur Com)涨幅较大，Novabay Pharmaceuticals, Inc.、知临集团、Gri Bio, Inc.较为活跃，换手率分别为126.64%、104.57%、62.17%，振幅较大的相关个股有知临集团、Nutriband Inc C/Wts (To Pur Com)、Coherus Biosciences, Inc.，振幅分别为43.88%、26.15%、16.30%。再鼎医药公司简介：再鼎医药有限公司是一家生物制药公司，专注于发现或许可、开发和商业化专利疗法，以解决未满足的医疗需求领域，包括肿瘤、自身免疫和传染病领域。 该公司的专利候选药物管线包括：ZL-2306，用于治疗包括卵巢癌和某些类型的乳腺癌和肺癌在内的多种实体瘤类型； ZL-2401，一类新型四环素衍生物中的抗生素； ZL-2301，一种靶向HCC的口服小分子药物。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2419600361"}

再鼎医药盘中异动 早盘大幅下跌5.01%

精彩评论

再鼎医药盘中异动早盘大幅下跌5.01%